Professor Ian Smith
- Consultant Medical Oncologist
- Professor of Cancer Medicine
- Head of the Breast Unit
Professor Smith has both a private and an NHS practice at The Royal Marsden.
Professor Ian Smith is Professor of Cancer Medicine at The Royal Marsden and the Institute of Cancer Research. He is also Head of the Breast Unit and sits on the Council of Governors at The Royal Marsden.
His initial medical training was in Edinburgh and then he came to The Royal Marsden for specialist training in cancer medicine. He also spent some time in Boston at the Dana-Farber Cancer Institute, Harvard. Over the years his principal clinical research interests have been in breast cancer, lung cancer and new drug development. He was involved in the early clinical development of several anticancer drugs that have subsequently proved effective in the clinic, including carboplatin and letrozole.
In the last decade he has become increasingly involved in neoadjuvant (preoperative) therapies as a research approach towards individualised treatments for breast cancer. He is currently Chief Investigator or UK Principal Investigator for several international multicentre breast cancer trials involving in particular targeted therapies and aromatase inhibitors. He publishes and lectures extensively. He was awarded the Susan G Komen for the Cure Brinker Award for Scientific Distinction at the 2009 San Antonio International Breast Cancer Conference.
Professor Smith was recently the first Chairman of the UK Breast Trials Intergroup and Chairman of the British Breast Group. He was the Scientific Chairman of the Breast Section of 2012 ESMO, and he has also chaired several national professional bodies including the Association of Cancer Physicians, the Royal College of Physicians Specialist Advisory Committee for Medical Oncology and the NCRI Lung Cancer Clinical Studies Group. He has just been appointed Co–chairman of the ASCO Clinical Guidelines Group for Chemotherapy in Metastatic Breast Cancer.